Schools in Big Ten Conference Form Cancer Research Consortium | GenomeWeb

NEW YORK (GenomeWeb News) – The universities that make up the Big Ten athletic conference in the US have shed their rivalries and banded together to harness their biomedical science resources in a new cancer research consortium.

The Big Ten Cancer Research Consortium aims to leverage the infrastructures, expertise, and clinical facilities available in these universities' cancer centers in joint oncology trials, the University of Michigan Health System said today. The consortium plans to use molecular diagnostics to study how cancers work and how to treat them.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.